PT  - JOURNAL ARTICLE
AU  - Christopher T. Sempos
AU  - Lu Tian
TI  - Adjusting Coronavirus prevalence estimates for laboratory test kit error
AID  - 10.1101/2020.05.11.20098202
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.11.20098202
4099  - http://medrxiv.org/content/early/2020/05/18/2020.05.11.20098202.short
4100  - http://medrxiv.org/content/early/2020/05/18/2020.05.11.20098202.full
AB  - Testing representative populations to determine the prevalence or percent of the population with active SARS-Cov-2 (COVID-19) infection and/or antibodies to infection is being recommended as essential for making public policy decisions to open-up or to continue enforcing national, state and local government rules to “shelter-in-place”. However, all laboratory tests are imperfect and have estimates of sensitivity and specificity less than 100% - in some cases considerably less than 100%. That error will lead to biased prevalence estimates. If the true prevalence of COVID-19 is low, possibly in the range of 1-5%, then testing error will lead to a constant background of bias that will most likely be larger and possibly much larger than the true prevalence itself. As a result, what is needed is a method for adjusting prevalence estimates for testing error. In this paper we outline methods for adjusting prevalence estimates for testing error both prospectively in studies being planned and retrospectively in studies that have been conducted. The methods if employed would also help to harmonize study results within countries and around the world. Adjustment can lead to more accurate prevalence estimates and to better policy decisions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo outside funding was used in the preparation of this manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData in the paper are available for public sources. No new data were generated in this research.